DENTSPLY SIRONA Statistics
Total Valuation
XRAY has a market cap or net worth of $3.71 billion. The enterprise value is $5.72 billion.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
XRAY has 198.78 million shares outstanding. The number of shares has decreased by -3.43% in one year.
| Current Share Class | 198.78M |
| Shares Outstanding | 198.78M |
| Shares Change (YoY) | -3.43% |
| Shares Change (QoQ) | -2.24% |
| Owned by Insiders (%) | 0.70% |
| Owned by Institutions (%) | 110.51% |
| Float | 197.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.87 |
| PS Ratio | 0.98 |
| Forward PS | 0.92 |
| PB Ratio | 1.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.09 |
| P/OCF Ratio | 6.89 |
| PEG Ratio | 1.76 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.49, with an EV/FCF ratio of 15.67.
| EV / Earnings | n/a |
| EV / Sales | 1.47 |
| EV / EBITDA | 9.49 |
| EV / EBIT | 22.26 |
| EV / FCF | 15.67 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.94.
| Current Ratio | 1.25 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 3.41 |
| Debt / FCF | 6.40 |
| Interest Coverage | 2.89 |
Financial Efficiency
Return on equity (ROE) is -13.99% and return on invested capital (ROIC) is 3.10%.
| Return on Equity (ROE) | -13.99% |
| Return on Assets (ROA) | 2.32% |
| Return on Capital (ROIC) | 3.10% |
| Revenue Per Employee | $260,000 |
| Profits Per Employee | -$27,533 |
| Employee Count | 15,000 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, XRAY has paid $54.00 million in taxes.
| Income Tax | 54.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.56% in the last 52 weeks. The beta is 1.03, so XRAY's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -37.56% |
| 50-Day Moving Average | 23.40 |
| 200-Day Moving Average | 27.29 |
| Relative Strength Index (RSI) | 35.07 |
| Average Volume (20 Days) | 4,916,858 |
Short Selling Information
The latest short interest is 13.77 million, so 6.93% of the outstanding shares have been sold short.
| Short Interest | 13.77M |
| Short Previous Month | 16.35M |
| Short % of Shares Out | 6.93% |
| Short % of Float | 6.98% |
| Short Ratio (days to cover) | 6.24 |
Income Statement
In the last 12 months, XRAY had revenue of $3.90 billion and -$413.00 million in losses. Loss per share was -$2.00.
| Revenue | 3.90B |
| Gross Profit | 2.04B |
| Operating Income | 257.00M |
| Pretax Income | -132.00M |
| Net Income | -413.00M |
| EBITDA | 603.00M |
| EBIT | 257.00M |
| Loss Per Share | -$2.00 |
Full Income StatementBalance Sheet
The company has $296.00 million in cash and $2.34 billion in debt, giving a net cash position of -$2.04 billion or -$10.26 per share.
| Cash & Cash Equivalents | 296.00M |
| Total Debt | 2.34B |
| Net Cash | -2.04B |
| Net Cash Per Share | -$10.26 |
| Equity (Book Value) | 2.49B |
| Book Value Per Share | 12.53 |
| Working Capital | 379.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $534.00 million and capital expenditures -$169.00 million, giving a free cash flow of $365.00 million.
| Operating Cash Flow | 534.00M |
| Capital Expenditures | -169.00M |
| Free Cash Flow | 365.00M |
| FCF Per Share | $1.84 |
Full Cash Flow StatementMargins
Gross margin is 52.18%, with operating and profit margins of 6.59% and -10.59%.
| Gross Margin | 52.18% |
| Operating Margin | 6.59% |
| Pretax Margin | -9.13% |
| Profit Margin | -10.59% |
| EBITDA Margin | 15.46% |
| EBIT Margin | 6.59% |
| FCF Margin | 9.52% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 3.42%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 3.42% |
| Dividend Growth (YoY) | 13.76% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | 3.43% |
| Shareholder Yield | 6.89% |
| Earnings Yield | -11.22% |
| FCF Yield | 9.91% |
Dividend DetailsAnalyst Forecast
The average price target for XRAY is $27.71, which is 48.54% higher than the current price. The consensus rating is "Buy".
| Price Target | $27.71 |
| Price Target Difference | 48.54% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 4.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 18, 2006. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 18, 2006 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
XRAY has an Altman Z-Score of 1.61 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.61 |
| Piotroski F-Score | 5 |